Julaeha, J. et al. 2021. Metabolic Syndrome Risk Associated with Atypical Antipsychotic Medication: A Case Report. Journal of Drug Delivery and Therapeutics. 11, 1 (Jan. 2021), 77–79. DOI:https://doi.org/10.22270/jddt.v11i1.4680.